Results 301 to 310 of about 297,887 (387)
Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial. [PDF]
Strømland PP+14 more
europepmc +1 more source
A senomorphic miRNA cocktail (E5), consisting of miR‐181a‐5p, miR‐92a‐3p, miR‐21‐5p, and miR‐186‐5p, was identified from a pool of miRNAs enriched in extracellular vesicles (EVs) derived from multiple functional human stem cell types. E5 reduces senescence and SASP markers both in cell culture and in aged mice.
Tianpeng Zhang+11 more
wiley +1 more source
Modulation of the Antitumor Response to Metformin, Caffeine, and Sodium Dichloroacetate by the Hypoxic Microenvironment in Lung Cancer Cells. [PDF]
Garcia-Martin MO+18 more
europepmc +1 more source
Metformin as a Tool to Target Aging.
N. Barzilai+3 more
semanticscholar +1 more source
RNAge is a transcriptional based computational approach to measure changes in cellular age upon experimental manipulation. In silico screening of a database of transcriptional changes from drug perturbations identified a novel aging agent that was applied to an hPSC model of neurodegenerative disease to trigger a late‐onset phenotype.
Chao Zhang+8 more
wiley +1 more source
Long-term effects of metformin on offspring health: A review of current evidence and future directions. [PDF]
Mayadunne T+6 more
europepmc +1 more source
SGLT2 inhibition with Enavogliflozin significantly improves cognitive function and reduces Aβ pathology in the 5XFAD mouse model of Alzheimer's disease. Through AMPK activation, Enavogliflozin enhances microglial mitochondrial function and Aβ phagocytosis while reducing neuroinflammation.
Jihui Han+5 more
wiley +1 more source
Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges. [PDF]
Saadati S+5 more
europepmc +1 more source